Doctors cannot be certain it was the treatment that cured Warwick Steele, but know of no other explanation.
Find out how to check for the signs and symptoms of testicular cancer.
A police officer who beat cancer twice has compiled an alternative bucket list with 101 things to do after you survive the disease.
A new breast cancer drug trialled at King's College London is to be blocked from routine NHS access under draft guidance issued by health watchdog NICE.
NICE say that Kadcyla can cost more than £90,000 per patient and is not effective enough to justify the price the NHS is being asked to pay - despite it extending women's lives by almost six months. Patients will be able to apply to their local NHS and to the Cancer Drugs Fund (CDF) for the drug.
But the decision, if made final later this year, would mean the drug would not be recommended for routine use in England on the NHS and women would have to rely on their doctors' successful application to the Cancer Drugs Fund.
A man who survived testicular cancer has urged other men to not be shy and to know how to check for signs, after it was revealed 75% of men do not know the symptoms of the disease.
Matt Hancock, a 32-year-old electrician from Twickenham, who found a lump on his testicles four years ago said he had no idea what he should be checking for before he was diagnosed:
I was young, fit and healthy, so I put off showing my GP. I was eventually referred to a hospital and thankfully the cancer was caught in time - I was one of the lucky ones.
I had my testicle removed and replaced with a prosthetic and have made a full recovery following 3 cycles of chemotherapy - I just wish I'd been more clued up.
It's bloody scary being told you have cancer, but as long as you act quickly then there is a very good chance you'll be ok.
My advice to men is to not be shy - get to know yourself and if you find something unusual, get it checked out straight away.
Just 16% of London men perform regular self-checks for testicular cancer, a new study has revealed.
Three quarters of men said they were unaware of how to correctly check themselves for the signs and symptoms of the disease.
After a survey of around 3,000 men, the charity Orchid released the following findings:
- Only 16% of men perform regular self-checks
- 10% of Londoners did not recognise any of the signs and symptoms of testicular cancer
- Around 47% of London men would shy away from showing their GP with 37% choosing to confide in their partner or Mum instead
The men's health charity Orchid has launched a confidential free phone National Male Cancer Helpline to answer any questions men might have about the disease and its symptoms.
Specialist nurses will staff the line Monday to Wednesday from 10am-6pm on 0808 802 0010.
Testicular cancer is the most common cancer in men aged between 15-45 years, with around 2,200-2,300 men being diagnosed each year. Awareness of the disease has improved in the past 5 years, but these findings show that vital life-saving health messages still aren't reaching the vast majority of men.
– Rebecca Porta, Orchid Chief Executive
We're calling on London's busy men to take a few minutes to learn about how to carry out simple self checks and to recognise the early warning signs and symptoms regardless of their work obligations and pace of life. Getting an early diagnosis is vital - if caught early, testicular cancer can be 98% curable.
Three quarters of London men are unaware of how to correctly check themselves for the signs and symptoms of testicular cancer, according to a new survey by a men's health charity.
Around half of the 3,000 men surveyed by Orchid, said they would 'shy away' from showing their GP if they discovered a lump.
Orchid Chief Executive Rebecca Porta said: "Awareness of the disease has improved in the past 5 years, but these findings show that vital life-saving health messages still aren't reaching the vast majority of men.
Getting an early diagnosis is vital - if caught early, testicular cancer can be 98% curable.
Scientists at Imperial Collegeare testing a new therapy to stop prostate cancer advancing to a deadly stage.
The team is developing "designer" proteins that could help patients once other methods have failed.
Each year around 37,000 men in the UK develop prostate cancer and 11,000 will die from the disease.